These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17032931)

  • 41. Thromboprophylaxis patterns and determinants in critically ill patients: a multicenter audit.
    Lauzier F; Muscedere J; Deland E; Kutsogiannis DJ; Jacka M; Heels-Ansdell D; Crowther M; Cartin-Ceba R; Cox MJ; Zytaruk N; Foster D; Sinuff T; Clarke F; Thompson P; Hanna S; Cook D; ;
    Crit Care; 2014 Apr; 18(2):R82. PubMed ID: 24766968
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thromboprophylaxis with low molecular weight heparin versus unfractionated heparin in intensive care patients: a systematic review with meta-analysis and trial sequential analysis.
    Beitland S; Sandven I; Kjærvik LK; Sandset PM; Sunde K; Eken T
    Intensive Care Med; 2015 Jul; 41(7):1209-19. PubMed ID: 25971389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk assessment and prophylaxis of venous thromboembolism in acutely and/or critically ill patients.
    Davidson BL
    Haemostasis; 2000; 30 Suppl 2():77-81; discussion 63. PubMed ID: 11251346
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thromboprophylaxis in non-surgical cancer patients.
    Cohen AT; Gurwith MM; Dobromirski M
    Thromb Res; 2012 Apr; 129 Suppl 1():S137-45. PubMed ID: 22682125
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial.
    Fowler RA; Mittmann N; Geerts WH; Heels-Ansdell D; Gould MK; Guyatt G; Krahn M; Finfer S; Pinto R; Chan B; Ormanidhi O; Arabi Y; Qushmaq I; Rocha MG; Dodek P; McIntyre L; Hall R; Ferguson ND; Mehta S; Marshall JC; Doig CJ; Muscedere J; Jacka MJ; Klinger JR; Vlahakis N; Orford N; Seppelt I; Skrobik YK; Sud S; Cade JF; Cooper J; Cook D; ;
    Trials; 2014 Dec; 15():502. PubMed ID: 25528663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A prospective observational study of a cohort of outpatients with an acute medical event and reduced mobility: incidence of symptomatic thromboembolism and description of thromboprophylaxis practices.
    Bosson JL; Pouchain D; Bergmann JF;
    J Intern Med; 2006 Aug; 260(2):168-76. PubMed ID: 16882282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cost effectiveness of thromboprophylaxis with a low-molecular-weight heparin versus unfractionated heparin in acutely ill medical inpatients.
    McGarry LJ; Thompson D; Weinstein MC; Goldhaber SZ
    Am J Manag Care; 2004 Sep; 10(9):632-42. PubMed ID: 15515996
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Prevention of venous thromboembolism in surgery, in laparoscopic surgery, in venous surgery and in urology].
    Gumulec J; Penka M; Bezdĕk R; Czudek S; Stursa M; Wróbel M; Brejcha M; Klodová D; Sumná E; Králová S
    Vnitr Lek; 2006 Mar; 52 Suppl 1():41-50. PubMed ID: 16637449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
    Beyer-Westendorf J; Lützner J; Donath L; Tittl L; Knoth H; Radke OC; Kuhlisch E; Stange T; Hartmann A; Günther KP; Weiss N; Werth S
    Thromb Haemost; 2013 Jan; 109(1):154-63. PubMed ID: 23197272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Barriers and facilitators of thromboprophylaxis for medical-surgical intensive care unit patients: a multicenter survey.
    Cook D; Duffett M; Lauzier F; Ye C; Dodek P; Paunovic B; Fowler R; Kho ME; Foster D; Stelfox T; Sinuff T; Zytaruk N; Clarke F; Wood G; Cox M; Kutsiogiannis J; Jacka M; Roussos M; Kumar H; Guyatt G; ;
    J Crit Care; 2014 Jun; 29(3):471.e1-9. PubMed ID: 24629574
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prophylaxis of venous thromboembolism in medical patients.
    Cohen AT; Alikhan R
    Curr Opin Pulm Med; 2001 Sep; 7(5):332-7. PubMed ID: 11584185
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Geerts WH; Bergqvist D; Pineo GF; Heit JA; Samama CM; Lassen MR; Colwell CW
    Chest; 2008 Jun; 133(6 Suppl):381S-453S. PubMed ID: 18574271
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adherence to pharmacological thromboprophylaxis orders in hospitalized patients.
    Fanikos J; Stevens LA; Labreche M; Piazza G; Catapane E; Novack L; Goldhaber SZ
    Am J Med; 2010 Jun; 123(6):536-41. PubMed ID: 20569760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Low-molecular-weight heparin (LMWH) in the treatment of thrombosis.
    Holzheimer RG
    Eur J Med Res; 2004 Apr; 9(4):225-39. PubMed ID: 15210403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
    Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thromboprophylaxis rates in US medical centers: success or failure?
    Amin A; Stemkowski S; Lin J; Yang G
    J Thromb Haemost; 2007 Aug; 5(8):1610-6. PubMed ID: 17663733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.
    Cohen AT; Nandini B; Wills JO; Ota S
    Thromb Res; 2010 Apr; 125 Suppl 2():S21-9. PubMed ID: 20434000
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dalteparin: an update of its pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic disease.
    Dunn CJ; Jarvis B
    Drugs; 2000 Jul; 60(1):203-37. PubMed ID: 10929935
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery.
    Bergqvist D
    Br J Surg; 2004 Aug; 91(8):965-74. PubMed ID: 15286956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.